Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, UK.
Heart. 2013 May;99(10):729-36. doi: 10.1136/heartjnl-2012-302925. Epub 2013 Feb 13.
To determine whether the effect of South Asian ethnicity differs between studies of incidence and prognosis of coronary disease.
Systematic literature review and meta-analysis, and cohort analysis from a national acute coronary syndrome (ACS) registry linked to mortality (National Institute of Cardiovascular Outcomes Research/Myocardial Infarction National Audit Project).
International for the review, and England and Wales for the cohort analysis.
The numbers of South Asians included in the meta-analysis were 111 555 (incidence) and 14 531 (prognosis) of whom 8251 were from the ACS cohort.
Incidence studies: non-fatal myocardial infarction or fatal coronary heart disease; prognostic studies: mortality; HRs for 1-year all-cause death in ACS cohort.
South Asians had higher incidence of coronary disease compared with white subjects (HR 1.35 95% CI 1.30 to 1.40) based on meta-analysis of nine studies. Among 10 studies on prognosis, South Asians had better prognosis compared with white subjects (HR 0.78 95% CI 0.74 to 0.82). In the ACS cohort, the impact of diabetes (42.4% of South Asians, 16.9% of white subjects) on 1-year mortality was stronger in South Asians than white subjects (age-adjusted HR 1.83 95% CI 1.59 to 2.11 vs 1.53 95% CI 1.49 to 1.57). However, prognosis was better in South Asians even among diabetics, older people and those living in areas of the highest social deprivation.
South Asian ethnicity is associated with higher incidence of coronary disease, but lower mortality once coronary disease is manifest. The dissociation between effects on incidence and prognosis suggests that public health initiatives to reduce inequalities in mortality between South Asian and white populations should focus on primary prevention. This is a CALIBER study with ClinicalTrials.gov Identifier: NCT01163513.
确定南亚裔族群在冠心病发病和预后研究中的作用是否存在差异。
系统文献回顾和荟萃分析,以及与死亡率相关的全国急性冠状动脉综合征(ACS)注册研究的队列分析(国家心血管结果研究/心肌梗死国家审计项目)。
国际范围内进行综述,英格兰和威尔士范围内进行队列分析。
荟萃分析纳入的南亚裔人数为 111 555 例(发病)和 14 531 例(预后),其中 8251 例来自 ACS 队列。
发病研究:非致死性心肌梗死或致死性冠心病;预后研究:死亡率;ACS 队列中 1 年全因死亡率的 HR。
基于 9 项研究的荟萃分析,南亚裔人群冠心病发病风险高于白人(HR 1.35,95%CI 1.30 至 1.40)。在 10 项预后研究中,南亚裔人群的预后好于白人(HR 0.78,95%CI 0.74 至 0.82)。在 ACS 队列中,糖尿病(南亚裔人群中占 42.4%,白人人群中占 16.9%)对 1 年死亡率的影响在南亚裔人群中比白人人群更强(年龄调整 HR 1.83,95%CI 1.59 至 2.11 比 1.53,95%CI 1.49 至 1.57)。然而,即使在糖尿病患者、老年人和生活在社会资源剥夺程度最高地区的人群中,南亚裔人群的预后也更好。
南亚裔族群与冠心病发病风险增加相关,但在冠心病发病后死亡率较低。发病和预后之间的这种差异表明,旨在减少南亚裔和白人群体之间死亡率不平等的公共卫生干预措施应侧重于一级预防。这是一项 CALIBER 研究,ClinicalTrials.gov 标识符为:NCT01163513。